Your browser doesn't support javascript.
loading
Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccine.
Takano, Tomohiro; Morikawa, Miwa; Adachi, Yu; Kabasawa, Kiyomi; Sax, Nicolas; Moriyama, Saya; Sun, Lin; Isogawa, Masanori; Nishiyama, Ayae; Onodera, Taishi; Terahara, Kazutaka; Tonouchi, Keisuke; Nishimura, Masashi; Tomii, Kentaro; Yamashita, Kazuo; Matsumura, Takayuki; Shinkai, Masaharu; Takahashi, Yoshimasa.
Afiliación
  • Takano T; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Morikawa M; Tokyo Shinagawa Hospital, Tokyo 140-8522, Japan.
  • Adachi Y; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Kabasawa K; Tokyo Shinagawa Hospital, Tokyo 140-8522, Japan.
  • Sax N; KOTAI Biotechnologies, Inc., Osaka 565-0871, Japan.
  • Moriyama S; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Sun L; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Isogawa M; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Nishiyama A; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Onodera T; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Terahara K; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Tonouchi K; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Nishimura M; Tokyo Shinagawa Hospital, Tokyo 140-8522, Japan.
  • Tomii K; Artificial Intelligence Research Center (AIRC), National Institute of Advanced Industrial Science and Technology (AIST), Tokyo 135-0064, Japan; AIST-Tokyo Tech Real World Big-Data Computation Open Innovation Laboratory (RWBC-OIL), Tokyo 152-8550, Japan.
  • Yamashita K; KOTAI Biotechnologies, Inc., Osaka 565-0871, Japan.
  • Matsumura T; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan. Electronic address: matt@niid.go.jp.
  • Shinkai M; Tokyo Shinagawa Hospital, Tokyo 140-8522, Japan. Electronic address: shinkai050169@gmail.com.
  • Takahashi Y; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan. Electronic address: ytakahas@niid.go.jp.
Cell Rep Med ; 3(5): 100631, 2022 05 17.
Article en En | MEDLINE | ID: mdl-35545084
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Vacuna BNT162 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Vacuna BNT162 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article